Literature DB >> 6891575

Pharmacokinetics and tissue penetration of azthreonam.

R Wise, A Dyas, A Hegarty, J M Andrews.   

Abstract

Six healthy male volunteers received 1 g of azthreonam each as an intravenous injection. Serial blood and cantharides-induced blister fluid samples were taken over the next 8 h. Urine samples were collected over 24 h. The concentration of azthreonam in serum was about 50 micrograms/ml at 0.5 h after injection and fell to 2 to 3 micrograms/ml at 8 h; the serum half-life was 1.93 h, and the volume of distribution was equivalent to 12% of the mean body weight. The plasma clearance was 89.0 ml/min, 73.7% of the dose being recovered in the urine within 24 h. Azthreonam rapidly penetrated blister fluid, reaching a maximum of 25.4 micrograms/ml at 1.8 h after administration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891575      PMCID: PMC185702          DOI: 10.1128/AAC.22.6.969

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Drug therapy. Clinical Pharmacokinetics (first of two parts).

Authors:  D J Greenblatt; J Kock-Weser
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

2.  Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou; J S Wells
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

3.  SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

Authors:  R Wise; J M Andrews; J Hancox
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  Monocyclic beta-lactam antibiotics produced by bacteria.

Authors:  R B Sykes; C M Cimarusti; D P Bonner; K Bush; D M Floyd; N H Georgopapadakou; W M Koster; W C Liu; W L Parker; P A Principe; M L Rathnum; W A Slusarchyk; W H Trejo; J S Wells
Journal:  Nature       Date:  1981-06-11       Impact factor: 49.962

5.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

6.  Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.

Authors:  E A Swabb; A A Sugerman; T B Platt; F G Pilkiewicz; M Frantz
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

  6 in total
  9 in total

1.  Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.

Authors:  M T Borin; G S Hughes; C R Spillers; R K Patel
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of aztreonam. An update.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 3.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

4.  Enterococcal superinfection and colonization with aztreonam therapy.

Authors:  P H Chandrasekar; B R Smith; J L LeFrock; B Carr
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of aztreonam.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

6.  Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.

Authors:  G Y Lavoie; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

7.  Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.

Authors:  T R Beam; R P Galask; L T Friedhoff; T B Platt; M A Leitz
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

8.  Penetration of aztreonam into human bronchial secretions.

Authors:  D L Bechard; S S Hawkins; R Dhruv; L T Friedhoff
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

9.  Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.

Authors:  C A McNulty; G M Garden; J Ashby; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.